Cytokinetics Stock Forecast

Sell candidate since Jul 28, 2026 Loss -2.92%

The Cytokinetics stock price fell by -4.09% on the last day (Friday, 31st Jul 2026) from $80.42 to $77.13. During the last trading day the stock fluctuated 4.97% from a day low at $76.98 to a day high of $80.81. The price has fallen in 7 of the last 10 days and is down by -3.8% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -553 thousand shares and in total, 2 million shares were bought and sold for approximately $118.71 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.12% during the next 3 months and, with a 90% probability hold a price between $81.53 and $102.00 at the end of this 3-month period.

CYTK Signals & Forecast

There are few to no technical positive signals at the moment. The Cytokinetics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $79.81 and $80.74. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -11.61%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Cytokinetics stock

Cytokinetics finds support from accumulated volume at $77.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.82 between high and low, or 4.97%. For the last week, the stock has had daily average volatility of 3.37%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CYTK) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Cytokinetics to open at $78.31, and during the day (based on 14 day Average True Range), to move between $75.65 and $78.61, which gives a possible trading interval of +/-$2.97 (+/-3.92%) up or down from last closing price. If Cytokinetics takes out the full calculated possible swing range there will be an estimated 3.92% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $77.09 (0.05%) than the resistance at $78.11 (1.27%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cytokinetics stock A Buy?

The Cytokinetics stock holds several negative signals and despite the positive trend, we believe Cytokinetics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.656 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $78.31 ( 1.52%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk